The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.

Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...

A pilot trial will assess whether concentrated bone marrow aspirate can prevent inflammation and reduce postsurgery pain and ...

Increased menstrual blood loss can be hard to measure and may detract from a woman’s quality of life, but a range of ...

New research showed some long COVID patients get symptom relief by taking an extended course of Paxlovid. Data are ...

Researchers have made strides creating strong, long-lasting imitation muscle as science fiction slowly evolves into fact.

The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to ...

A recent survey revealed that many patients were worried about the physical effects of radiation, and more than one third ...

Women’s antidepressant use dropped by nearly half during pregnancy without a corresponding increase in psychotherapy use and ...

Exercise and nutritional prehabilitation are associated with lower complication rates and possible improvements in other ...

Consumption of high-dosage caffeine products can have a negative impact on behavior among youths during their middle school ...

New 20-year data show a survival rate of 90% with few repeat surgeries after this complex operation that can only be ...